There’s a certain genre of drug question that never goes out of style: “Can this thing I’m already taking also […]

Courts can triple damages for willful infringement. A flawed freedom-to-operate search is not a defense — it is evidence you

Unit price is the number everyone fights over. It’s also the number that matters least. Pharmaceutical procurement has a dirty

The Clock You Can Buy In the drug industry, time is not just money. It is the only thing that

Introduction: The Law That Reshaped American Medicine In 1984, a California congressman named Henry Waxman and a Utah senator named

The Problem With Waiting Most formulation vendors approach business development reactively. They wait for a drug to lose exclusivity, watch

There’s a quiet shift happening in pharmacology that doesn’t show up neatly in prescribing guidelines or FDA labels. It shows

The Number Nobody Puts in the Model Every pharma M&A deal starts with a revenue forecast. Bankers build complex discounted

Every pharmaceutical executive knows the word “patent cliff.” Fewer can accurately define the legal machinery underneath it. Fewer still understand